vividlook icad

At this year’s RSNA, computer-aided detection (CAD) solutions target MRI. These new CAD systems include:

• VividLook MRI prostate analysis solution, provides more diagnostic information by utilizing all available time points (ATP), creating colorized images based on signal changes defined by tumor physiology. This post processing software package is designed to provide a reliable means of visualizing the presence and pattern of contrast induced enhancement of MRI images in the prostate, helping radiologists distinguish benign from malignant lesions.

• SpectraLook CAD technology is designed to assist radiologists in distinguishing potential cancers in the breast as part of their overall analysis of the MRI procedure results. It provides radiologists with more diagnostic information by creating colorized images based on direct signal changes due to contrast agent influx and efflux rates using key physiological measures that relate to tumor physiology. These physiological markers can aid in the analysis of large MR data sets.

• PrecisionPoint, iCAD’s interventional planning solution for breast MRI, provides radiologists with an automatic calculation of the location and depth of a targeted region of interest making biopsies easier, faster, and more reliable for both grid and post and pillar methods. PrecisionPoint is an integrated module within CADvue, iCAD’s MRI review software solution. Using CADvue and PrecisionPoint, radiologists have a quick, easy way to secure all the necessary data for an interventional procedure, streamlining their planning and performance of MRI-guided percutaneous breast biopsies.

• CADvue is iCAD’s MRI review software and analysis solution that facilitates the analysis of ATP colorized images and quantitative data. CADvue allows the user to create standard and customized reports that enable the radiologist to communicate time-sensitive breast and prostate MR study results to referring physicians. CADvue software also provides an efficient method for clinicians to compare studies of the same patient performed over time to assess the morphology and kinetic changes. CADvue compares several parameters including EVF, PERM, and volume of selected regions of interest enabling improved quantitative analysis.

 


Related Content

News | Mammography

April 29, 2025 — iCAD, a global provider of clinically proven AI-powered cancer detection solutions, has announced a ...

Time April 29, 2025
arrow
News | Mammography

April 24, 2025 — GE HealthCare will feature its latest advancements in diagnostic accuracy and patient-centered breast ...

Time April 24, 2025
arrow
News | Artificial Intelligence

March 10, 2025 — Lunit, a provider of AI-powered solutions for cancer diagnostics and therapeutics, has published a ...

Time March 10, 2025
arrow
News | Artificial Intelligence

Feb. 19, 2025 — SimonMed Imaging and HeartLung Technologies have signed a strategic partnership to offer HeartLung's AI ...

Time March 04, 2025
arrow
News | Ultrasound Imaging

Jan. 28, 2025 — GE HealthCare recently announced it has received 510(k) clearance from the United States Food and Drug ...

Time January 29, 2025
arrow
News | Breast Imaging

Jan. 8, 2025 — ScreenPoint Medical has acquiredf Biomediq A/S, a research-based company focused on the research ...

Time January 10, 2025
arrow
News | Breast Imaging

Dec.11, 2024 — iCAD, Inc., a provider of clinically proven AI-powered cancer detection solutions, recently announced ...

Time December 18, 2024
arrow
News | Mammography

Dec. 5, 2024 — At RSNA 2024, Lunit and Volpara Health announced their unified vision, focusing on a comprehensive ...

Time December 05, 2024
arrow
News | Mammography

Nov. 26, 2024 — GE HealthCare has introduced the Pristina Via* mammography system designed to enhance the screening ...

Time December 02, 2024
arrow
News | Artificial Intelligence

Dec. 2, 2024 — Lunit recently unveiled follow-up findings from the ScreenTrustCAD trial. This study, conducted at Capio ...

Time December 02, 2024
arrow
Subscribe Now